(Q41094555)

26 September 2017

title

Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes (English)

1 reference

26 September 2017

0 references

Viret C

1

1 reference

26 September 2017

Davodeau F

2

1 reference

26 September 2017

Guilloux Y

3

1 reference

26 September 2017

Bignon JD

4

1 reference

26 September 2017

Semana G

5

1 reference

26 September 2017

Breathnach R

6

1 reference

26 September 2017

Jotereau F

7

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 January 1993

1 reference

European Journal of Immunology

26 September 2017

published in

1 reference

26 September 2017

volume

23

1 reference

26 September 2017

issue

1

1 reference

26 September 2017

page(s)

141-146

1 reference

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

HLA class I nucleotide sequences, 1991.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

HLA-B27 and HLA-A2 subtypes: structure, evolution and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive ability

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

An HLA-A2 population variant with structural polymorphism in the alpha 3 region

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230123

7 January 2021

Identifiers

DOI

10.1002/EJI.1830230123

1 reference

26 September 2017

1 reference